Real World Evidence | eMAX Health

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

For years, real-world evidence strategies across pharmaceutical organizations have been built primarily on administrative claims data. Claims datasets have long served as the backbone for understanding utilization trends, reimbursement activity, and treatment adoption...

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

Launch strategies are built on carefully modeled assumptions — projected uptake curves, coverage expectations, budget impact forecasts, and prioritized segments designed to drive early performance. But once a product enters the market, projections meet operational...

From Insight to Activation: Building a Cross-Functional Market Access Operating Model

Market access teams have spent years investing in better insight. More data. More analyses. More evidence. Today, the differentiator isn’t insight, it’s activation. Across the industry, organizations are generating increasingly sophisticated analyses, yet...

What Payers Will Demand From Evidence in 2026

The start of a new year brings more than refreshed planning cycles, it brings a reset in payer expectations. As 2026 gets underway, payers are signaling that the evidence bar is rising. Traditional endpoints alone are no longer sufficient. Retrospective analyses...

The Payer Playbook for 2026: What We’re Hearing From MAVA® Panels Right Now

2026 is taking shape and payers are telling us exactly how they plan to evaluate price, value, evidence, and contracting in the months ahead. Across MAVA®’s ongoing payer panels, sentiment cycles, and rapid-turn advisory sprints, several themes have emerged. And...

« Older Entries

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

From Insight to Activation: Building a Cross-Functional Market Access Operating Model

What Payers Will Demand From Evidence in 2026

The Payer Playbook for 2026: What We’re Hearing From MAVA® Panels Right Now

Search by Category:

Recent Posts:

Search by Keyword:

The EMR-First Shift: Why Market Access Evidence Is Moving Beyond Claims

Beyond Coverage: The 90-Day Clinical Reality Check for Post-Launch Access Performance

From Insight to Activation: Building a Cross-Functional Market Access Operating Model

What Payers Will Demand From Evidence in 2026

The Payer Playbook for 2026: What We’re Hearing From MAVA® Panels Right Now

Search by Category:

Recent Posts:

Search by Keyword:

Cookie Consent

Your Privacy Choices

Strictly Necessary (Always Active)

Analytics & Performance

Marketing & Advertising